Sanofi/GSK trial woes delay a billion COVID-19 shots by nine monthsSanofi and GlaxoSmithKline have said their COVID-19 vaccine has hit a snag in clinical development, prompting analysts to Share XSanofi/GSK trial woes delay a billion COVID-19 shots by nine monthshttps://pharmaphorum.com/news/sanofi-gsk-trial-woes-delay-a-billion-covid-19-shots-by-nine-months/
CLL patients in England to get AZ’s Calquence after okay from NICENHS England is to grant immediate access to AstraZeneca’s cancer drug Calquence (acalabrutinib) for certain patients with chronic Share XCLL patients in England to get AZ’s Calquence after okay from NICEhttps://pharmaphorum.com/news/cll-patients-in-england-to-get-azs-calquence-after-okay-from-nice/
Bluebird trumpets long-term data from beta-thalassaemia gene therapybluebird bio has presented long-term data from its Zynteglo one-time gene therapy for the blood disorder beta-thalassaemia, as Share XBluebird trumpets long-term data from beta-thalassaemia gene therapyhttps://pharmaphorum.com/news/bluebird-trumpets-long-term-data-from-beta-thalassaemia-gene-therapy/
Sanofi/Regeneron on notice as FDA reviews GSK’s Nucala for nasal polypsSanofi and Regeneron’s Dupixent has had the US market for the treatment of chronic rhinosinusitis with nasal polyps Share XSanofi/Regeneron on notice as FDA reviews GSK’s Nucala for nasal polypshttps://pharmaphorum.com/news/dupixent-on-notice-as-fda-reviews-gsks-nucala-for-nasal-polyps/
First COVID-19 vaccinations begin in UK hospitalsA 90-year-old woman has become the first person given a COVID-19 vaccine as part of the UK’s mass Share XFirst COVID-19 vaccinations begin in UK hospitalshttps://pharmaphorum.com/news/first-covid-19-vaccinations-begin-in-uk-hospitals/
Scotland says no to Daiichi Sankyo’s cholesterol drug NilemdoThe Scottish Medicines Consortium (SMC) has rejected Daiichi Sankyo’s new cholesterol-lowering drug Nilemdo for use by NHS Scotland, Share XScotland says no to Daiichi Sankyo’s cholesterol drug Nilemdohttps://pharmaphorum.com/news/scotland-says-no-to-daiichi-sankyos-cholesterol-drug-nilemdo/
UK faces “V-Day” and largest ever vaccination programmeTuesday has been dubbed “V-day” in the UK, when the first doses of Pfizer/BioNTech’s coronavirus vaccine will be Share XUK faces “V-Day” and largest ever vaccination programmehttps://pharmaphorum.com/news/uk-faces-v-day-and-challenge-of-mass-covid-19-vaccination-programme/
Social media erupts as anti-vaxxers respond to COVID-19 vaccine approvalIn the midst of the jubilation about the UK’s emergency approval of Pfizer/BioNTech’s COVID-19 shot in the UK Share XSocial media erupts as anti-vaxxers respond to COVID-19 vaccine approvalhttps://pharmaphorum.com/news/social-media-erupts-as-anti-vaxxers-respond-to-covid-19-vaccine-approval/
Pfizer/BioNTech to deliver COVID-19 vaccine to UK after approvalPfizer and BioNTech are preparing to deliver their COVID-19 vaccine to the UK after the country’s drugs regulator Share XPfizer/BioNTech to deliver COVID-19 vaccine to UK after approvalhttps://pharmaphorum.com/news/pfizer-biontechs-coronavirus-vaccine-approved-in-uk/
